DOTmed August 2, 2024
R1 RCM Inc., based in Murray, Utah, has been acquired by private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) for approximately $8.9 billion in cash. TowerBrook, which already owns about 36% of R1’s shares, and CD&R will buy out the remaining shares for $14.30 each.
The acquisition price marks a 29% premium over R1’s closing stock price on February 23, 2024, prior to New Mountain Capital’s initial non-binding acquisition proposal. The deal has received unanimous approval from a special committee of R1’s board of directors, composed solely of independent directors. The committee led the negotiations, advised by independent legal and financial advisors.
“TowerBrook has been an outstanding long-term investor and partner to R1 and shares our...
Today's Sponsors
Today's Sponsor